Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients

Hiroshima Journal of Medical Sciences

Volumn 49, Issue 2, 2000, Pages 109-116

  Nishisaka, Takashi ^a,b   Takeshima, Yukio ^a   Inai, Kouki ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

Author keywords

Bronchial dysplasia; Loss of heterozygosity; Microdissection; p53 gene mutation

Indexed keywords

PRIMER DNA;

ARTICLE; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 9; GENETICS; HETEROZYGOSITY LOSS; HUMAN; LUNG TUMOR; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRECANCER; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 9; DNA PRIMERS; GENES, P53; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MUTATION; PRECANCEROUS CONDITIONS;

EID: 0034201912     PISSN: 00182052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Auerbach, O., Petrick, T.G., Stout, A.P., Statsinger, A.L., Muehsam, G.E., Forman, J.B. and Gere, J.B. 1956. The anatomical approach to the study of smoking and bronchogenic carcinoma. A preliminary report of forty-one cases. Cancer 9: 76-83.
2. Auerbach, O., Gere, J.B., Forman, J.B., Petrick, T.G., Smolin, H.J., Muehsam, G.E., Kassouny, D.Y. and Stout, A.P. 1957. Changes in the bronchial epithelium in relation to smoking and cancer of the lung. N. Engl. J. Med. 256: 97-104.
3. Bennett, W.P., Colby, T.V., Travis, W.D., Borkowski, A., Jones, R.T., Metcalf, R.A., Samet, J.M., Takeshima, Y., Vahakangas, K.H., Soini, Y., Paakko, P., Welsh, J.A., Trump, B.F. and Harris, C.C. 1993. p53 protein accumulates frequency in early bronchial neoplasia. Cancer Res. 53: 4817-4822.
4. Cannon-Albright, L.A., Goldner, D.E., Meyer, L.J., Lewis, C.M., Andersen, D.E., Foutain, J.W., Hegi, M.E., Wiseman, R.W., Petty, E.M., Bale, A.E., Olopade, O.I., Diaz, M.O., Kwiatkiwski, D.J., Piepkon, M.W., Zone, J.J. and Skolnic, M.H. 1992. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-9p22. Science 258: 1148-1152.
5. Chung, G.Y.T., Sundaresan, V., Hasleton, P., Rudd, R., Taylor, R. and Rabbits, P.H. 1995. Sequential molecular genetic changes in lung cancer development. Oncogene 11: 2591-2598.
6. Chung, G.T.Y., Sundaresan, V., Hasleton, P., Rudd, R., Taylor, R. and Rabbits, P.H. 1996. Clonal evaluation of lung tumors. Cancer Res. 56: 1609-1614.
7. El-Nagger, A.K., Batsakis, J.G., Wang, G. and Lee, M.S. 1993. PCR-based RFLP screening of the commonly delated 3p loci in renal cortical neoplasms. Diagn. Mol. Pathol. 2: 269-276.
8. El-Naggar, A.K., Hurr, K., Barsakis, J.G., Luna, M.A., Goepfert, H. and Huff, V. 1995. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous cell carcinoma. Cancer Res. 55: 2656-2659.
9. Gao, H., Wangw, L.D., Zhous, Q., Hong, J.Y., Huang, T.Y. and Yung, C.S. 1994. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk population in Henan, China. Cancer Res. 54: 4342-4346.
10. Gazdar, A. 1994. The molecular and cellular basis of human lung cancer. Anticancer Res. 13: 2095-2097.
11. Hibi, K., Takahashi, T., Yamakawa, K., Ueda, R., Sekido, Y., Ariyoshi, Y., Suyama, M., Takagi, H., Nakamura, Y. and Takahashi, T. 1992. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 7: 445-449.
12. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. 1991. p53 mutations in human cancers. Science 253: 49-53.
13. Horio, Y., Takahashi, T., Kuroishi, T., Hibi, K., Suyama, M., Niimi, T., Shimokata, K., Yamakawa, K., Nakamura, Y., Ueda, R. and Takahashi, T. 1993. Prognostic significance of p53 mutation and 3p deletion in primary resected non-small cell cancer. Cancer Res. 53: 1-4.
14. Horio, Y., Suzuki, H., Ueda, R., Koshikawa, T., Sugiura, T., Ariyoshi, Y., Takahashi, T. and Takahashi, T. 1994. Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation. Oncogene 9: 1231-1235.
15. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D.D., Minna, J.D. and Gazdar, A.F. 1995. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273: 558-563.
16. Hussussian, C.J., Struewing, J.P., Goldstein, A.M., Higgins, P.A.T., Ally, D.S., Sheahan, M.D., Clark, Jr. W.H., Tucker, M.A. and Dracopoli, N. 1994. Germline p16 mutations in familial melanoma. Nat. Genet. 8: 15-21.
17. Jones, M.H. and Nakamura, Y. 1992. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chrom. 5: 89-90.
18. Jones, M.H., Yamakawa, K. and Nakamura, Y. 1992. Isolation and characterization of 19 dinucleotides repeat polymorphism on chromosome 3p. Hum. Mol. Genet. 1: 131-133.
19. Jones, M.H. and Nakamura, Y. 1992. Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphism. Oncogene 7: 1631-1634.
20. Kishimoto, Y., Sugio, K., Hung, J.Y., Virami, A.K., Mcintire, D.D., Minna, J.D. and Gazdar, A.F. 1995. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J. Natl. Cancer Inst. 87: 1224-1229.
21. Klein, K., Vignaud, M., Sadmi, M., Plenat, F., Borelly, J., Duprez, A., Martinet, Y. and Martinet, N. 1993. Squamous metaplasia expression of proto-oncogene and p53 in lung cancer patients. Lab. Invest. 68: 26-32.
22. Mitsudomi, T., Steinberg, S.M., Oie, J.L., Muishine, R., Pheips, J.V., Minna, J.D. and Gazdar, A.F. 1991. Ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res. 51: 4999-5010.
23. Nees, M., Homann, N., Discher, H., Andl, T., Enders, C., Herold-Mende, C., Schuhmann, A. and Bosch, FX. 1993. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumor. Cancer Res. 53: 4189-4196.
24. Nobori, T., Miura, K., Wu, D.J., Lois, A., Takabayashi, K. and Carson, D.A. 1994. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756.
25. Sambrook, T., Fritsch, E.F. and Maniatis, T. 1989. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press: New York.
26. Sato, S., Nakamura, Y. and Tsuchiya, E. 1994. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res. 54: 5652-5655.
27. Sozzi, G., Miozzo, M., donghi, R., Pilotti, S., Cariani, C.T., Pastorino, U., Porta, G.D. and Pierotti, M.A. 1992. Detections of 17p and p53 mutation in preneoplastic lesions of the lung. Cancer Res. 52: 6079-6082.
28. Sozzi, G., Miozoo, M., Donghi, R., Pastorino, U., Piloti, S., Giarola, M., De Gregorio, L.D., Manenti, G., Radice, P., Minoletti, F., Porta, G.D. and Pierotti, M.A. 1995. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res. 55: 135-140.
29. Sundaresan, V., Gandy, P., Hasleton, P., Rudd, R., Sinha, G., Bleehen, N.M. and Rabbitts, P. 1992. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus. Oncogene 7: 1989-1997.
30. Suzuki, H., Takahashi, T., Suyama, M., Ariyoshi, Y., Takahashi, T. and Ueda, R. 1992. p53 mutaions in non-small cell lung cancer in Japan: association between mutation and smoking. Cancer Res. 52: 734-736.
31. Takahashi, T., Nau, M.M., Chiba, I., Birrer, M.J., Rosenberg, R.K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A.F. and Minna, J.D. 1989. p53: a frequent target for genetic abnormalities in lung cancer. Science 246: 491-484.
32. Tuchiya, E., Nakamura, Y., Weng, S.Y., Nakagawa, K., Tsuchiya, S., Sugano, H. and Kitagawa, T. 1992. Allelotype of non-small cell lung carcinoma-comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res. 52: 2478-2481.
33. Thiberville, L., Rayne, P., Vielkind, S.J., Leriche, J., Horsman, D., Nouvet, G., Palcic, B. and Lam, S. 1995. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res. 55: 5133-5139.
34. Walker, C., Robertoson, L.J., Myskow, M.W., Pendleton, N. and Dixon, G.R. 1994. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinoma. Br. J. Cancer. 70: 297-303.
35. Washimi, O., Nagata, M., Osada, H., Ueda, R., Koshikawa, T., Seki, T., Takahashi, T. and Takahashi, T. 1995. In vivo occurrence of p16 (MTS1) and p15 (MTS2) alteration preferentially in non-small cell lung cancers. Cancer Res. 55: 514-517.
36. Lydiatt, W.M., Anderson, P.E., Bazzana, T., Casale, M., Hughes, C.J., Huvos, A.G., Lydiatt, D.D. and Schantz, S.P. 1998. Molecular suppor for field cancerization in the Head and Neck. Cancer 82: 1376-1380.
37. Wright, D.K. and Mannos, M.M. 1990. PCR Protocols: A guide to method and applications. pp. 153-158. Academic Press: San Diego.
38. Yokota, J., Wada, M., Shimosato, Y., Terada, M. and Sugimura, T. 1987. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. 84: 9252-9256.